Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Information Storage and Retrieval | 1 | 2011 | 31 | 0.400 |
Why?
|
| Leptin | 3 | 2017 | 118 | 0.370 |
Why?
|
| Research Personnel | 1 | 2011 | 155 | 0.360 |
Why?
|
| Internet | 1 | 2011 | 211 | 0.340 |
Why?
|
| Sarcoidosis | 1 | 2007 | 11 | 0.290 |
Why?
|
| Comorbidity | 4 | 2007 | 623 | 0.290 |
Why?
|
| Receptors, Notch | 2 | 2017 | 33 | 0.260 |
Why?
|
| Lung | 1 | 2007 | 446 | 0.230 |
Why?
|
| Health Services Accessibility | 4 | 2011 | 560 | 0.190 |
Why?
|
| Information Dissemination | 2 | 2014 | 59 | 0.180 |
Why?
|
| Hypertension | 4 | 2011 | 796 | 0.180 |
Why?
|
| Obesity | 3 | 2017 | 1067 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 45 | 0.160 |
Why?
|
| Interleukin-1 | 1 | 2017 | 35 | 0.150 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Aspirin | 1 | 2017 | 49 | 0.150 |
Why?
|
| Primary Health Care | 4 | 2009 | 294 | 0.150 |
Why?
|
| Georgia | 4 | 2011 | 174 | 0.140 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 66 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 78 | 0.140 |
Why?
|
| Schools, Medical | 2 | 2011 | 198 | 0.140 |
Why?
|
| Renal Dialysis | 2 | 2008 | 120 | 0.130 |
Why?
|
| Middle Aged | 15 | 2017 | 10129 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 111 | 0.130 |
Why?
|
| Humans | 26 | 2017 | 37093 | 0.130 |
Why?
|
| Disease Progression | 3 | 2017 | 601 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 13 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 63 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2014 | 66 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2017 | 1908 | 0.110 |
Why?
|
| Female | 17 | 2017 | 20969 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 1067 | 0.100 |
Why?
|
| Health Promotion | 2 | 2010 | 653 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 5 | 0.100 |
Why?
|
| PubMed | 1 | 2011 | 4 | 0.100 |
Why?
|
| Informatics | 1 | 2011 | 3 | 0.100 |
Why?
|
| Search Engine | 1 | 2011 | 6 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 17 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2011 | 2026 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 31 | 0.100 |
Why?
|
| Male | 16 | 2017 | 20025 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 807 | 0.100 |
Why?
|
| Community Health Centers | 2 | 2009 | 45 | 0.100 |
Why?
|
| Adult | 12 | 2011 | 11712 | 0.090 |
Why?
|
| Aged | 10 | 2017 | 6741 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2010 | 6 | 0.090 |
Why?
|
| Urban Population | 2 | 2010 | 333 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2011 | 400 | 0.090 |
Why?
|
| Coronary Angiography | 2 | 2011 | 90 | 0.090 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 63 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 29 | 0.090 |
Why?
|
| Disease Management | 1 | 2010 | 61 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2011 | 494 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 68 | 0.080 |
Why?
|
| Focus Groups | 1 | 2011 | 348 | 0.080 |
Why?
|
| Community Networks | 2 | 2006 | 108 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2009 | 56 | 0.080 |
Why?
|
| Rural Health Services | 1 | 2009 | 44 | 0.080 |
Why?
|
| Treatment Refusal | 1 | 2008 | 20 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 225 | 0.080 |
Why?
|
| Appointments and Schedules | 1 | 2008 | 19 | 0.080 |
Why?
|
| Health Behavior | 2 | 2010 | 537 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2011 | 446 | 0.080 |
Why?
|
| Health Literacy | 1 | 2010 | 105 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 610 | 0.080 |
Why?
|
| Quality of Health Care | 2 | 2005 | 138 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2009 | 484 | 0.070 |
Why?
|
| Students, Medical | 1 | 2009 | 130 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2010 | 2721 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 72 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 208 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2006 | 13 | 0.070 |
Why?
|
| Chemistry, Clinical | 1 | 2006 | 1 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2006 | 5 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 149 | 0.070 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2006 | 4 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 66 | 0.070 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 82 | 0.070 |
Why?
|
| Registries | 2 | 2005 | 335 | 0.070 |
Why?
|
| Logistic Models | 4 | 2011 | 923 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2007 | 184 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2006 | 168 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 35 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2005 | 41 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2231 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2005 | 117 | 0.060 |
Why?
|
| Risk Factors | 3 | 2011 | 3562 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 84 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 448 | 0.060 |
Why?
|
| Myocardium | 1 | 2006 | 235 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 519 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 183 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 128 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 730 | 0.060 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 39 | 0.060 |
Why?
|
| Malaria, Cerebral | 1 | 2004 | 31 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 70 | 0.060 |
Why?
|
| Education, Medical | 1 | 2005 | 104 | 0.060 |
Why?
|
| Blood Pressure | 4 | 2011 | 646 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 233 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2005 | 233 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 219 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 583 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1502 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 864 | 0.050 |
Why?
|
| Time Factors | 3 | 2017 | 1742 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 643 | 0.050 |
Why?
|
| Heart Failure | 1 | 2005 | 235 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 276 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1198 | 0.050 |
Why?
|
| Asthma | 1 | 2005 | 380 | 0.050 |
Why?
|
| Poverty | 3 | 2010 | 348 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 664 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 2379 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 400 | 0.040 |
Why?
|
| Prevalence | 3 | 2008 | 1455 | 0.040 |
Why?
|
| Diffusion | 1 | 2017 | 50 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2017 | 3 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2010 | 149 | 0.040 |
Why?
|
| Diamines | 1 | 2017 | 7 | 0.040 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2017 | 18 | 0.040 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 35 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2017 | 12 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2017 | 15 | 0.040 |
Why?
|
| Thiazoles | 1 | 2017 | 74 | 0.040 |
Why?
|
| Antibodies | 1 | 2017 | 141 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 130 | 0.040 |
Why?
|
| Health Surveys | 2 | 2009 | 373 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 275 | 0.040 |
Why?
|
| Endometrium | 1 | 2017 | 60 | 0.030 |
Why?
|
| United States | 3 | 2014 | 4223 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2010 | 534 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2010 | 215 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 337 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 235 | 0.030 |
Why?
|
| Nanostructures | 1 | 2017 | 134 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 349 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 202 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 326 | 0.030 |
Why?
|
| Water | 1 | 2017 | 296 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2010 | 1378 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 1369 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 8 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2005 | 191 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 41 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 32 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2013 | 40 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 76 | 0.030 |
Why?
|
| Adolescent | 3 | 2010 | 5363 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 98 | 0.030 |
Why?
|
| Sternotomy | 1 | 2011 | 2 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2011 | 11 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 23 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 36 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 225 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 434 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 96 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 249 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 325 | 0.020 |
Why?
|
| Chest Pain | 1 | 2011 | 37 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 233 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2011 | 85 | 0.020 |
Why?
|
| Telephone | 1 | 2010 | 34 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2011 | 187 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 144 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 571 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 517 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 313 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 247 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 265 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 194 | 0.020 |
Why?
|
| Domestic Violence | 1 | 2009 | 30 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 38 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 4268 | 0.020 |
Why?
|
| Social Perception | 1 | 2009 | 62 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2009 | 136 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 15081 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 442 | 0.020 |
Why?
|
| C-Peptide | 1 | 2007 | 7 | 0.020 |
Why?
|
| Fasting | 1 | 2007 | 54 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 68 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2007 | 97 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 138 | 0.020 |
Why?
|
| Child | 2 | 2006 | 3131 | 0.020 |
Why?
|
| Reticulocyte Count | 1 | 2006 | 3 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2006 | 6 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2006 | 9 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 455 | 0.020 |
Why?
|
| Blood Coagulation Tests | 1 | 2006 | 5 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 104 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 54 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 103 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2006 | 107 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 418 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 25 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 188 | 0.020 |
Why?
|
| Nephrology | 1 | 2005 | 17 | 0.020 |
Why?
|
| Unemployment | 1 | 2005 | 23 | 0.020 |
Why?
|
| Flowmeters | 1 | 2005 | 1 | 0.020 |
Why?
|
| Metered Dose Inhalers | 1 | 2005 | 2 | 0.020 |
Why?
|
| Teaching Materials | 1 | 2005 | 8 | 0.020 |
Why?
|
| Insulin | 1 | 2007 | 236 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2007 | 353 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2007 | 189 | 0.020 |
Why?
|
| Financing, Government | 1 | 2005 | 19 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2005 | 50 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2006 | 103 | 0.020 |
Why?
|
| Heart Rate | 1 | 2006 | 253 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 139 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Education | 1 | 2005 | 55 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2005 | 104 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 67 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 225 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 215 | 0.020 |
Why?
|
| Receptors, CCR3 | 1 | 2004 | 10 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2005 | 100 | 0.010 |
Why?
|
| Educational Status | 1 | 2005 | 313 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 61 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 321 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2009 | 609 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 215 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 854 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 185 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2009 | 583 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 237 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 935 | 0.010 |
Why?
|
| Health Personnel | 1 | 2005 | 228 | 0.010 |
Why?
|
| Alcoholism | 1 | 2005 | 240 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 5913 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 739 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 284 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 628 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 940 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 767 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 596 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 1418 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 1346 | 0.010 |
Why?
|